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Introduction 
 
An ‘Addisonian crisis’ is one of the most feared endocrine emergencies and requires 
early recognition and prompt treatment to prevent serious consequences. Strictly-
speaking, Addison’s disease describes an autoimmune adrenalitis leading to cortisol 
deficiency. However, the term ‘Addisonian crisis’ is often used on the acute medical 
take to describe the acute clinical presentation associated with adrenal failure, 
irrespective of the underlying aetiology. Cortisol deficiency originating from the 
adrenal gland is known as primary adrenal insufficiency (PAI) whereas if the origin is 
from the pituitary or hypothalamus then this is known as secondary adrenal 
insufficiency. (Figure 1). 
 
This article aims to summarise the causes of adrenal insufficiency in a manner that is 
easy to remember and to revise the symptoms and signs of its acute presentation. The 
emergency medical management will be presented together with top tips for treating 
and investigating the condition up until discharge.     
Aetiology  
Primary and secondary causes of adrenal insufficiency can be broadly divided into 
causes using the “I” mnemonic: Immunological, Invasion, Infection, Infiltration, 
Iatrogenic, Infants (congenital) and Injury (Table 1).        
   
Table 1: Causes of primary and secondary adrenal insufficiency using the “I” 
mnemonic 
 
Causes Primary  Secondary  
“Immunological” Isolated autoimmune 
adrenalitis (Addison’s 
Disease), autoimmune 
polyglandular syndromes 
Lymphocytic hypophysitis 
“Invasion” Bilateral adrenal metastasis, 
lymphoma 
Pituitary tumours (e.g. 
Macroadenoma, 
craniopharyngioma, 
meningioma, metastasis) 
“Infection” Tuberculosis, HIV, CMV, 
fungal infections 
Tuberculosis, histoplasmosis 
“Infiltration” Sarcoidosis, amyloidosis, 
hemochromatosis, 
Granulomatosis with 
polyangiitis (Wegener’s 
granulomatosis), 
Sarcoidosis, amyloidosis, 
hemochromatosis, 
“Infarction” Haemorrhage, Waterhouse- 
Friderichsen syndrome, 
antiphospholipid syndrome, 
hypoperfusion, anti-coagulant 
therapy 
Apoplexy, Sheehan 
syndrome 
“Iatrogenic” Bilateral adrenalectomy, 
withdrawal from long-term 
steroid therapy, drugs 
(mitotane, tyrosine kinase 
inhibitors) 
Hypophysectomy (pituitary 
surgery), cranial 
radiotherapy, ipilimumab  
“Infants” 
 
Congenital adrenal hyperplasia 
(e.g. 21 hydroxylase 
deficiency, 11Beta hydroxylase 
deficiency), X-linked 
adrenoleukodystrophy 
Genetic mutations e.g. TBX 
19, combined pituitary 
hormone deficiency (CPHD) 
“Injury”   Traumatic brain injury  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic demonstrating the hypothalamic-pituitary-adrenal (HPA) axis 
and its disruption in primary vs. secondary adrenal insufficiency  
 
 
 
 
  
Summary of causes of primary adrenal insufficiency (PAI) 
The most common cause of PAI is autoimmune adrenalitis. This is more likely in 
individuals with co-existent autoimmune disease but also occurs in isolation in up to a 
third of cases. Addison’s disease is found in the monogenic autoimmune 
polyglandular syndrome type 1 in combination with mucocutaneous candidiasis, 
hypoparathyroidism and ectodermal dystrophy that is seen in childhood, as well as the 
more prevalent adult type 2 disease (Kahaly and Frommer, 2017). Thomas Addison 
originally described the pathological features of adrenal tuberculosis (TB) in 1855 and 
to this day, TB remains the second commonest cause of PAI in the UK and should be 
considered in all new presentations of PAI.  
 
Other causes of PAI that may present on the medical take include invasion of the 
adrenal glands in metastatic disease (usually from primary disease in the colon, lung 
or breast) and hypoxic injury secondary to hypovolaemic or septic shock. PAI is also 
seen in rarer syndromes such as antiphospholipid syndrome, congenital adrenal 
hyperplasia and adrenoleukodystrophy (where very long chain fatty acids can 
accumulate in the adrenal cortex and also the brain causing neurodegeneration).  
 
Summary of causes of secondary adrenal insufficiency  
Secondary adrenal insufficiency refers to a state of adrenal suppression due to 
insufficiency of adrenocorticotrophic hormone production from the pituitary gland. 
Pituitary adenomas as well as other sellar tumours such as meningiomas, 
craniopharyngioma and pituitary metastases may all cause ACTH deficiency and 
adrenal suppression. Traumatic and blast brain injury are other causes of secondary 
adrenal suppression (Baxter et al., 2013) as well as pituitary apoplexy and Sheehan’s 
syndrome in the post-partum period (Table 1).  Addisonian crisis is less common in 
secondary vs. primary adrenal insufficiency due to preserved aldosterone production, 
which is not under ACTH control, and typically less extensive cortisol reduction.  
  
Drug- related adrenal insufficiency   
Patients with established PAI may present to the A&E department in Addisonian 
crisis having omitted their steroid replacement medication for a variety of reasons. 
The most common cause is a vomiting illness preventing absorption of corticosteroid. 
A careful history and/or presence of a medic alert bracelet/card should alert you to 
this.  
 
An alternative scenario is following cessation of long-term corticosteroid treatment. A 
5mg dose of prednisolone (or equivalent) over a 4 week period (topical, inhaled, oral 
or injected) can cause suppression of the hypothalamic-pituitary-adrenal axis (Bancos 
et al., 2015) . On cessation of treatment some patients may present in an adrenal 
crisis. A careful history enquiring as to the use of corticosteroid is warranted, 
including the use of steroid creams and inhalers. Similarly, patients who have been 
successfully treated for Cushing’s disease or those who may be taking insufficient 
doses of hydrocortisone whilst on mitotane for adrenal cancer may be particularly 
vulnerable to an adrenal crisis.  
 
Clinical presentation 
A classical Addisonian crisis presents as a shocked patient with electrolyte and 
metabolic disturbance and a suggestive history. A summary of the history, 
examination and laboratory findings typical of an adrenal crisis is presented in Table 
2.  
  
Table 2. Summary of potential symptoms, signs and laboratory findings during a 
suspected adrenal crisis  
 
Symptoms  Weight loss 
Malaise 
Pre-syncope or syncopal episodes 
Confusion 
Gastrointestinal (GI) disturbance  
Salt-craving  
Hyperpigmentation 
Examination findings Hypotension (postural if not in shock) 
Hyperpigmentation (palmar creases, buccal 
mucosa, old scars, nipples) 
Septic source/fever (GI, urine, chest, viral 
illness) 
?MI ?surgical abdomen 
Laboratory findings  Hyponatraemia 
Hyperkalaemia 
Acute kidney injury from hypoperfusion 
Normochromic anaemia  
Hypoglycaemia especially in children. 
 
  
History  
It is important to remember that the majority of patients presenting in adrenal crisis 
already have a diagnosis of adrenal insufficiency (Hahner et al., 2010). In such 
patients, it is important to check drug adherence. Patients may have run out of their 
prednisolone or hydrocortisone, or vomited shortly after having taken it. In new cases 
of adrenal insufficiency patients or their carers may report non-specific symptoms 
such as weight loss, malaise, anorexia, nausea, vomiting, abdominal pain, dizziness 
and joint pain and in PAI more specific symptoms include salt-craving and 
hyperpigmentation. There may be a history of long-term corticosteroid use that has 
recently stopped or a history of a pituitary tumour/surgery.  
 
Co-existent autoimmune disease may be present and it is important to ask directly 
regarding a history of hypothyroidism, type 1 diabetes, vitiligo and autoimmune 
hepatitis among other autoimmune tendencies including a family history of these 
conditions. PAI may present with an apparent improvement in glycaemic control in 
long standing type 1 diabetes or recurrent hypoglycaemia in patients who do not 
adjust insulin doses accordingly. Metastatic disease should be suspected in those with 
oncological disease, and tuberculosis should be considered in high risk groups. 
 
Examination 
Signs of hypovolaemic shock are usually present (hypotension/tachycardia/cerebral 
hypoperfusion). Co-existent sepsis may have precipitated the crisis so a careful 
examination of all systems is necessary. In one survey, vomiting and/or a diarrhoeal 
illness was responsible for more than 50% of cases of adrenal crisis followed by flu-
like illness and associated major infections and surgical procedures. Chest and urine 
infections, migraine, allergic reactions, septicaemia, myocardial infarction and 
hypoglycaemia were other less common causes (White and Arlt, 2010). 
 
In a new presentation of Addison’s disease there may be signs of hyperpigmentation 
due to excessive stimulation of skin melanocortin receptors by high ACTH levels. It 
is important to look in palmar creases, buccal mucosa, old scars and nipples for signs 
of increased pigmentation or other areas exposed to mechanical stress.  
 
Initial investigations 
Hyponatraemia may be present in primary and secondary adrenal insufficiency and 
hyperkalaemia in PAI due to mineralocorticoid deficiency. Hypoglycaemia may or 
may not be present but is more common in children. Thyroid stimulating hormone 
may be mildly elevated. A random cortisol of <100 nmol/L in a patient with clinical 
features of an Addisonian crisis is suggestive of adrenal insufficiency and in the 100-
350 nmol/L range, adrenal insufficiency cannot be ruled out. Even seemingly 
‘adequate’ cortisol concentrations above this cannot absolutely exclude adrenal 
insufficiency as they may be inappropriately low for a critically ill patient. Because 
cortisol is a diurnal hormone, it is also important to bear in mind that healthy 
individuals often have low afternoon cortisol levels and random cortisol levels can be 
misleading. However a blood sample before any steroid is administered can be very 
informative and a sample should ideally be sent for ACTH and cortisol with the 
electrolytes before any treatment is administered for later review. If adrenal crisis is 
suspected clinically then immediate management should be instigated before cortisol 
and ACTH results are available.  
 
Clinical Management 
The diagnosis of an adrenal crisis should be made on clinical grounds initially. If the 
patient is severely unwell then potentially life-saving hydrocortisone treatment should 
be instigated immediately, without waiting to confirm the diagnosis biochemically. If 
the patient is haemodynamically stable then it may be reasonable to consider 
performing a short synacthen test prior to commencing hydrocortisone treatment. 
 
Emergency management (0-24 hours) (Box 1.) 
Hydrocortisone (immediate bolus injection of hydrocortisone 100mg i.v. or i.m. 
followed by continuous intravenous infusion of 100mg hydrocortisone over 24 hrs or 
4.2mg per hour). An alternative regimen would be 50mg every 6 hours (i.v. or i.m.) 
(Arlt, 2016).. The plasma cortisol profile is smoother with an IM bolus compared to 
IV due to the short half-life of cortisol.  
 
Fluid resuscitation should be with isotonic saline solution. The first litre should be 
given over 1 hour followed by 4-6 hourly. Monitor for signs of fluid overload.  
 
Top Tips Box 1. Emergency management of an adrenal crisis 
1) Hydrocortisone 100mg bolus (i.m or i.v) 
2) Followed by continuous intravenous infusion of 100mg over 24 hours. Or 
hydrocortisone 50mg every 6 hours i.m or i.v 
3) 1000ml normal saline over 1 hour 
4) Followed by 4-6 L normal saline over 24 hours (caution in elderly and those 
with potential cardiac failure). 
 
On-going management  
Specialist endocrine input should be sought at the earliest opportunity to guide on-
going management and further investigations. A switch to oral hydrocortisone or 
prednisolone should be undertaken as soon as the patient is able to eat and drink. The 
most common replacement dose of hydrocortisone is 10mg on waking, 5mg at noon 
and 5mg at 4pm. The dose can be adjusted if necessary in the endocrine clinic. Steroid 
replacement at these physiological doses does not need to be taken with food.  
 
An alternative may be to consider a once daily dose of prednisolone (2-5mg) and this 
is a focus of ongoing research (EL. Williams, 2016 , Smith et al., 2017). This may be 
a preferred option for patients who find thrice daily hydrocortisone difficult to 
remember and where once daily prednisolone may be a better option for them. 
Dexamethasone does not have a role in the long-term treatment of adrenal 
insufficiency.  
 
In the long run, it is important to remember that excessive steroid replacement is also 
a cause of increased morbidity and mortality(Hammarstrand et al., 2017). 
 
 
Laboratory Investigations  
 
Following initial emergency management the diagnosis of adrenal insufficiency needs 
to be confirmed or excluded by conducting a short synacthen test. This test provides a 
supraphysiological stimulus (250 mcg synthetic ACTH) to cortisol production and 
enables investigation of adrenal reserve. The cut-off for stimulated cortisol at 30 
minutes will vary according to the assay used but usually ranges from 450-500 
nmol/L(El-Farhan et al., 2013). A baseline ACTH helps to determine whether the 
adrenal insufficiency is primary (high ACTH) or secondary in origin (normal or low 
ACTH). Ideally the test should be performed in the morning, so that baseline cortisol 
and ACTH can be accurately assessed, although other times are also acceptable since 
it is the 30-minute cortisol value which is used to guide management. Endocrine 
advice should be sought where there is any uncertainty in interpretation. 
 
  
Top Tips Box 2 – How to perform a short synacthen test.  
 
Contraindications: 
Pregnancy, pituitary surgery within 6 weeks, Oral contraceptive pill (OCP) or 
hormone replacement therapy (HRT). 
Preparation: 
Final dose of hydrocortisone midday on day before. Stop HRT/OCP at least 6 
weeks before test.  
Method  
1) Insert 18-20 g cannula 
2) 0900 hrs take blood for cortisol (yellow top vacutainer) and ACTH (purple top 
vacutainer). Send ACTH sample lab immediately on ice. Flush cannula. 
3) Give 250 micrograms tetracosactride i.m. (ideally) or i.v.  
4) 0930h: After discarding 5 ml blood, take 3 ml blood for cortisol. Flush cannula 
5) 1000h*: After discarding 5 ml blood, take 3 ml blood for cortisol. Flush cannula) 
Interpretation: 
Stimulated plasma cortisol >450-500 nmol/L**  (or increment rise >150 nmol/L) = 
normal response  
*Different centres may perform 60 minute cortisol measurement, ** check local lab cut-off. 
 
 
Further specialist investigations 
If adrenal insufficiency is confirmed, further tests will be determined by whether it is 
primary or secondary in nature and to seek the underlying cause (Table 1) For PAI, 
adrenal antibodies are useful to determine an autoimmune aetiology and for secondary 
adrenal insufficiency, biochemical and radiological assessment of the pituitary is 
usually required. Thyroid function and glycaemic status should be re-checked when 
steroid replete and the patient is well, as hypoadrenalism itself can affect thyroid and 
glycaemic status that can reverse following treatment, or may reveal true autoimmune 
hypothyroidism or diabetes and the lack of cortisol may have influenced the thyroid 
and glucose results.  
 
Mineralocorticoid replacement 
 
In PAI there is invariably a need for mineralocorticoid replacement in the form of oral 
fludrocortisone. This is important to prevent postural hypotension and electrolyte 
disturbance. At higher doses of hydrocortisone (i.e. >50mg in 24 hours) there is no 
need for fludrocortisone as hydrocortisone in these doses possesses sufficient 
mineralocorticoid activity. It is important to minimise the dose of glucocorticoid to 
minimise side effects, and to do this there is a requirement for daily fludrocortisone 
replacement (typically 100 mcg once daily). Fludrocortisone should be commenced 
by an endocrinologist, either prior to discharge or very soon afterwards in an 
outpatient clinic. Serum/plasma aldosterone will be low and renin will be high in 
mineralocorticoid deficiency, hence potassium and renin measurements, along with an 
assessment of postural blood pressure change, can be used to titrate fludrocortisone 
dose in the clinic. Most patients need between 3mg and 4mg of prednisolone once 
daily together with fludrocortisone 100mcg (Smith etal). Hydrocortisone 10mg + 5mg 
+ 5mg daily is an alternative to once daily prednisolone.  
Discharge and Follow-up  
 
All patients (and family/carers) with confirmed adrenal insufficiency should be 
educated about their condition. They should be alerted to sick day rules (Box 3) and 
encouraged to carry a steroid emergency card www.endocrinology.org/adrenal-crisis 
and/or a medic alert bracelet.  All patients should be referred to a specialist endocrine 
clinic. A discharge check list can be found in Box 4.   
Top Tips Box 3. Sick Day Rules 
 
1. Double hydrocortisone dose during a febrile illness or one that requires 
antibiotics or bed rest (ensure patient has additional dose of hydrocortisone 
so dose can be doubled for at least 7 days) 
2. Glucocorticoids may need to be administered either i.v. or i.m. during a 
vomiting or diarrhoeal illness. The patient (or carer) can be taught to self-
administer hydrocortisone. Provide a Hydrocortisone Emergency 
Injection Kit and ensure it always remains in date.  
 
 
 
Top Tips Box 4. Discharge Check List  
 
New diagnosis of adrenal insufficiency: 
1) Is the patient well and taking 15-20 mg hydrocortisone or 2mg to 4mg 
prednisolone, and in PAI fludrocortisone 100 mg daily? 
2) Has the patient had a short synacthen test and inpatient endocrine review? 
3) Has the patient been educated about their condition, given an explanation of 
sick day rules and given a steroid emergency card? 
4) Has the patient been referred to the endocrine outpatient clinic?  
Established diagnosis of adrenal insufficiency: 
1) Is the patient well and taking usual dose of hydrocortisone or prednisolone? 
2) Has the reason for adrenal crisis been explored? 
3) Have sick day rules been re-discussed? 
4) Does the patient carry a steroid alert card or have a medic alert bracelet? 
5) Does the patient have an endocrine outpatient appointment booked? 
 
  
Key points: 
 
1) ‘Addisonian crisis’ is a life-threatening endocrine emergency that requires 
early recognition and treatment of the condition. 
2) Most cases of adrenal crisis are in patients who have established adrenal 
insufficiency. 
3) An adrenal crisis is more common in primary vs. secondary adrenal 
insufficiency due to additional lack of mineralocorticoid. 
4) When suspected clinically, an adrenal crisis must be treated with prompt 
hydrocortisone replacement and fluid resuscitation. 
5) In new suspected cases of adrenal insufficiency, the diagnosis should be 
confirmed with a short synacthen test prior to discharge. 
6) If confirmed, patients should be established on oral hydrocortisone (usually 
15-20 mg in divided daily doses) or 3-4mg prednisolone once daily. 
7) All patients should be educated regarding ‘sick day’ rules and encouraged to 
carry a medic alert bracelet and/or steroid emergency card.  
8) All patients should be under specialist endocrine follow-up.   
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